Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-02-07 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 496959

Date	Daily Closing Price	Open	High	Low	Volume
07 Fri Feb 2025	2208.15	2202.00	2249.70	2175.15	0.93 times
06 Thu Feb 2025	2260.65	2000.00	2364.00	1992.00	4.961 times
05 Wed Feb 2025	1999.35	1969.00	2016.85	1960.00	2.187 times
04 Tue Feb 2025	1960.40	1981.45	2007.00	1950.60	0.277 times
03 Mon Feb 2025	1981.45	1955.95	1994.85	1921.00	0.22 times
31 Fri Jan 2025	1977.15	1994.75	2013.70	1961.55	0.534 times
30 Thu Jan 2025	1980.05	2003.75	2009.95	1975.00	0.441 times
29 Wed Jan 2025	1983.95	2028.20	2028.20	1969.95	0.456 times
28 Tue Jan 2025	2023.15	2064.85	2077.45	1981.10	0.206 times
27 Mon Jan 2025	2062.30	2094.15	2094.15	2031.50	0.434 times

Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 2237.8, for a target of 2144.6 or 2066.87

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	1921.00
Downside Target	1961.55
Downside Target	2039.05
Downside Target	2094.15
Downside Target	2141.35
Upside Target	2248.95
Upside Target	2307.00
Upside Target	2364.00
Upside Target	2457.75
Upside Target	2500.00
Upside Target	2742.95
Upside Target	2889.90

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	1964.77
Downside Intraday Target	1721.38
Upside Intraday Target	2407.77
Upside Intraday Target	2607.38
Downside Intraday Target	2164.38

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
07 Fri Feb 2025	2208.15	1955.95	2364.00	1921.00	4.142 times
31 Fri Jan 2025	1977.15	2094.15	2094.15	1961.55	1.124 times
24 Fri Jan 2025	2099.55	2065.00	2202.00	2039.05	2.148 times
17 Fri Jan 2025	2063.30	2143.00	2165.80	1987.00	1.227 times
10 Fri Jan 2025	2190.40	2236.00	2248.95	2141.35	0.751 times

Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
07 Fri Feb 2025	2208.15	1955.95	2364.00	1921.00	1.503 times
31 Fri Jan 2025	1977.15	2235.00	2272.00	1961.55	1.617 times
31 Tue Dec 2024	2251.85	2436.00	2457.75	2158.40	0.973 times
29 Fri Nov 2024	2444.40	2729.00	2742.95	2307.00	0.867 times

Scroll below to view daily charts

Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Glaxosmithkline Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2138.44 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.